Table 5.
Univariable and Multivariable Competing Risks Regression for PSA Failure
Univariable PSA Failure | Multivariable PSA Failure | ||||||
---|---|---|---|---|---|---|---|
HR | [95% CI] | p-value | HR | [95% CI] | p-value | ||
Biopsy Result | Positive | 4.39 | [3.00 – 6.42] | <.001 | 3.87 | [2.56 – 5.85] | <.001 |
Negative | REF | REF | |||||
Gleason Score | >=7 | 1.47 | [1.01 – 2.14] | 0.043 | 1.44 | [0.96 – 2.17] | 0.08 |
<=6 | REF | REF | |||||
Pre-RT PSA (ng/mL) | 10–20 | 1.23 | [0.81 – 1.85] | 0.60 | 1.21 | [0.79 – 1.86] | 0.37 |
>=20 | 1.16 | [0.71 – 1.90] | 1.40 | [0.78 – 2.52] | 0.26 | ||
0–10 | REF | REF | |||||
T-Stage | T3 | 1.08 | [0.69 – 1.68] | 0.75 | 0.81 | [0.48 – 1.36] | 0.43 |
T1-T2 | REF | REF | |||||
Hormones | No | 1.66 | [1.14 – 2.42] | 0.009 | 1.63 | [1.07 – 2.49] | 0.023 |
Yes | REF | REF | |||||
NCCN Risk Score | High | 1.97 | [1.07 – 3.60] | 0.07 | --- | ||
Medium | 1.52 | [0.82 – 2.81] | --- | ||||
Low | REF | --- |